General Information

Tremendous variation exists in the types of interventions prescribed for Cerebral Palsy (CP), the timing and sequencing of interventions, and their intensity or frequency across practitioners, settings, and geographical areas. Clinical decisions are still mostly based on inconsistently informed opinion because clear evidence-based practice guidelines are not yet available. While the number and quality of studies investigating the efficacy or effectiveness of treatments in CP have increased markedly in recent years, the number of viable treatment options is increasing without evidence on what constitutes optimal management.

Attendees will be international leaders in research on underlying pathology and therapeutic interventions in cerebral palsy, those with expertise in research methodologies from this and other related fields that have a high potential for providing the necessary data, representatives of families of children with CP and adults with CP, research funding organizations, professional organizations, and relevant federal agencies. There will be an emphasis on goals of research and current gaps, and additional methodologies complementary to Randomized Controlled Trials to address the gaps, including: the exploration of large data solutions, comparative effectiveness designs, and studies that will incorporate the complexity and variability of patients and interventions and their separate and combined effects on outcomes.

Version: 2.0.0